US20200093585A1 - Methods And Devices For Anchoring A Gastroenterologic Sleeve - Google Patents
Methods And Devices For Anchoring A Gastroenterologic Sleeve Download PDFInfo
- Publication number
- US20200093585A1 US20200093585A1 US16/698,816 US201916698816A US2020093585A1 US 20200093585 A1 US20200093585 A1 US 20200093585A1 US 201916698816 A US201916698816 A US 201916698816A US 2020093585 A1 US2020093585 A1 US 2020093585A1
- Authority
- US
- United States
- Prior art keywords
- ring
- sheath
- stomach
- digestive tract
- configuration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004873 anchoring Methods 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims description 19
- 210000002784 stomach Anatomy 0.000 claims abstract description 46
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 19
- 230000007246 mechanism Effects 0.000 claims abstract description 13
- 230000005012 migration Effects 0.000 claims abstract 2
- 238000013508 migration Methods 0.000 claims abstract 2
- 210000001198 duodenum Anatomy 0.000 claims description 14
- 230000003993 interaction Effects 0.000 claims description 3
- 210000001187 pylorus Anatomy 0.000 claims 13
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 210000003236 esophagogastric junction Anatomy 0.000 abstract description 5
- 208000008589 Obesity Diseases 0.000 description 8
- 239000000463 material Substances 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 230000004580 weight loss Effects 0.000 description 5
- 206010025476 Malabsorption Diseases 0.000 description 4
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 4
- 238000007681 bariatric surgery Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 208000012696 congenital leptin deficiency Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000001022 morbid obesity Diseases 0.000 description 2
- 235000020830 overeating Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010025477 Malabsorption conditions Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000001434 dietary modification Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000020888 liquid diet Nutrition 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 208000001797 obstructive sleep apnea Diseases 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00818—Treatment of the gastro-intestinal system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/041—Bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/045—Stomach, intestines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
Definitions
- the present invention relates generally to improved methods and devices for anchoring a gastroenterologic sleeve within the stomach without reliance on sutures, staples, or other mechanisms that puncture the stomach wall.
- the anchoring system of the present invention prevents movement of the sleeve in both directions, thereby preventing the sleeve from being passed through the digestive system but also from refluxing up the esophagus.
- Treatment options include dietary modification, very low-calorie liquid diets, pharmaceutical agents, counseling, exercise programs and surgery. Diet and exercise plans often fail because most individuals do not have the discipline to adhere to such plans. When diet and exercise fail, many try dietary supplements and drugs or other ingestible preparations promoted as being capable of suppressing appetite or inducing satiety. In general, these techniques for treating compulsive overeating/obesity have tended to produce only a temporary effect. The individual usually becomes discouraged and/or depressed after the initial rate of weight loss plateaus and further weight loss becomes harder to achieve. The individual then typically reverts to the previous behavior of compulsive overeating.
- Surgical procedures that restrict the size of the stomach and/or bypass parts of the intestine are the only remedies that provide lasting weight loss for the majority of morbidly obese individuals. Surgical procedures for morbid obesity are becoming more common based on long-term successful weight loss result.
- Bariatric surgery is a treatment for morbid obesity that involves alteration of a patient's digestive tract to encourage weight loss and to help maintain normal weight.
- Known bariatric surgery procedures include jejuno-ileal bypass, jejuno-colic shunt, biliopancreatic diversion, gastric bypass, Roux-en-Y gastric bypass, gastroplasty, gastric banding, vertical banded gastroplasty, and silastic ring gastroplasty.
- a gastroenterologic sleeve which is essentially a prosthetic liner for the stomach and/or duodenum
- malabsorption can be induced without permanently modifying the GI tract.
- the sleeve simply provides a physical barrier between the food eaten and the absorptive stomach and duodenic walls.
- the methods and devices of the present invention are directed to methods and devices for implanting a gastroenterologic sleeve into the stomach and/or duodenum without using puncturing fasteners such as staples or sutures.
- a plurality of pessary rings is incorporated into a sleeve such that the rings expand until they contact the stomach walls.
- This embodiment takes advantage of the fact that the inlet and outlet of the stomach are much smaller than the interior of the stomach. Hence, once the rings have expanded, they are too large to migrate out of the stomach.
- Another embodiment involves the use of a loose, yet expandable matrix implanted in the stomach.
- the matrix allows interaction between the stomach and food yet provides an anchor to which a sleeve lining the duodenum is attached.
- the matrix eliminates the possibility of the sleeve migrating through the intestinal tract.
- Another embodiment employs two pessary rings and a band or other constrictor, such as a lap band.
- the pessary rings are installed inside the esophageal-stomach junction and have an inherent expansive force.
- a lap band is placed around the outside of the stomach, between the pessary rings, and has a squeezing force. Hence, the pessary rings and the lap band interact to lock each other in place.
- a sheath, tube or sleeve is attached to the pessary rings and extends into the stomach to cause food to bypass some or all of the stomach. The sheath may also extend into the duodenum such that a portion of the small intestine is also bypassed.
- FIG. 1 is an elevation of an embodiment of the present invention installed within a stomach
- FIG. 2 is an elevation of an embodiment of the present invention installed within a stomach
- FIG. 3 is an elevation of an embodiment of the present invention installed within a stomach
- FIG. 4 is an elevation of an embodiment of the present invention installed within a stomach.
- FIG. 5 is a perspective view of a delivery device that may be used to delivery the devices of the present invention.
- FIG. 1 there is shown an embodiment of the present invention that includes a device 10 for creating a malabsorption condition in the stomach and/or duodenum.
- the device 10 generally includes an absorption-limiting or preventing sheath or tube 20 that is attached at a proximal end 22 to an anchoring device 40 .
- the anchoring device 40 includes a plurality of rings 42 , such as pessary rings for example, connected together by thin connectors 44 .
- the rings 42 are resilient and collapsible such that they may be compressed into elongate members for introduction into the stomach via the esophagus with a catheter or endoscope. Upon release from the delivery device, the rings 42 expand and orient themselves in a spaced-apart fashion.
- the rings are sized and arranged according to the shape of the stomach and it is envisioned that each device will be sized proportionately to the size of the patient, if necessary.
- the connectors 44 are thin, thread-like connectors that prevent the rings 42 from twisting.
- the connectors 44 also function to combine the rings 42 into a single anchor and further create large gaps through which food may contact the stomach walls for digestion.
- the thin connectors 44 may be replaced by a sleeve-like material. It is further envisioned that a combination of thin connectors 44 and connectors made of sleeve-like material may be used to control the area of the stomach that participates in the digestive process. It is further contemplated that the thin connectors 44 may be replaced by a semi-permeable sleeve material that allows some of the food to come into contact with stomach acid for digestion.
- FIG. 2 shows another embodiment of a device 50 of the present invention.
- the device 50 also includes an absorption-limiting or preventing sheath or tube 20 that is attached at a proximal end 22 to an anchoring device 60 .
- the anchoring device 60 is constructed of a loose, expandable matrix 62 .
- the matrix 62 is constructed such that some or all of the food entering the stomach is permitted to interact with the stomach in the digestive process.
- the matrix may be constructed of a self-expanding material such as Nitinol, or any suitable, digestive-resistant material.
- the anchoring device 60 is sized to substantially fill the stomach cavity when expanded and also to conform to the shape of the stomach, thereby providing a stable anchor for the tube 20 .
- FIG. 3 shows an embodiment of a device 70 that includes sheath 80 connected to an anchoring device 90 .
- the sheath 80 is sized and constructed to prevent food from contacting the upper stomach, thereby limiting digestion.
- the sheath 80 is connected to the anchoring device 90 , which includes components that are internal and external to the gastroesophageal junction.
- the interior components of the anchoring device 90 include two pessary rings 92 , each connected to the sheath 80 .
- the pessary rings 92 are self-expanding and, when in place, place a mild pressure on the inside of the esophagus.
- the exterior components of the anchoring device 90 include a lap band 94 and an inflation device 96 .
- the lap band 94 is fastened around the outside of the gastroesophageal junction between the locations of the pessary rings 92 .
- the anchoring device 90 also includes a pump 98 , such as a hand pump, connected to the lap band 94 via a tube 100 .
- the lap band 94 is inflated with an acceptable fluid, such that the lap band places an inward pressure on the gastroesophageal junction between the external pressure points of the pessary rings 92 .
- the lap band 94 and the pessary rings 92 cooperate to prevent movement of the anchoring device 90 . It is further contemplated that the lap band 94 can be controlled using the pump 98 to control the amount and rate that food can enter the stomach, as well as preventing gastroesophageal reflux disease (GERD).
- GFD gastroesophageal reflux disease
- FIG. 4 depicts another embodiment of the device 70 in which a sheath 110 is attached to the anchoring device 90 is longer and extends well into the duodenum.
- This embodiment provides a solution for completely bypassing the stomach and some or all of the duodenum.
- the sheath 110 could be constructed, partly or entirely, of a semi-permeable material that allows some gastric interaction between the food and the digestive system. Doing so may prevent some of the undesirable effects of malabsorption, such as the various forms of malabsorption syndrome.
- FIG. 5 shows one example of a delivery device 120 for use in implanting devices 10 or 50 .
- the delivery device 120 includes a endoscopic catheter 130 surrounded by a sheath catheter 150 .
- a space 152 exists between the endoscopic catheter 130 and the sheath catheter 150 that is sized to allow the device 10 or 50 to be tubularly loaded therein.
- the endoscopic catheter 130 includes a pulling wire 132 with an attachment mechanism 134 at a distal end thereof.
- the endoscopic catheter 130 also includes an endoscope 136 and a steering device (not shown).
- a portion of the endoscopic catheter 130 is radiopaque.
- radiopaque bands may be incorporated into the distal end of the delivery device 120 .
- a device 10 or 50 is loaded into the delivery device 120 such that the endoscopic catheter 130 passes through the interior lumen of the device 10 or 50 and the sheath catheter 150 surrounds the exterior of the device 10 or 50 .
- the device 10 or 50 is loaded such that the distal end of the device 10 or 50 is at the distal end of the delivery device 120 .
- the attachment mechanism 134 is attached to the distal end of the device 10 or 50 .
- the delivery device 120 is then navigated transesophageally into and through the stomach and into the duodenum to a desired depth.
- the delivery device 120 is then retracted while the pulling wire 132 is advanced through the endoscopic catheter 130 such that the distal end of the pulling wire 132 remains somewhat stationary with respect to the duodenum.
- the pulling wire 132 pulls the device 10 or 50 from the distal end of the delivery device via the attachment mechanism 134 .
- the endoscope 136 provides an interior view of the device 10 or 50 being deployed. Hence, verification that the device 10 or 50 is not twisted or otherwise fouled is provided.
- the attachment device 134 is released from the distal end of the device 10 or 50 and the pulling wire 132 is retracted into the endoscopic catheter 130 . Then the entire delivery device 120 is removed from the body.
- the delivery device 120 may be similarly used to deploy the device 70 of FIGS. 3 and 4 . However, laparoscopic installation of the lap band 94 is also required.
Abstract
Description
- This application claims priority to patent application Ser. No. 12/865,706, filed Dec. 15, 2010 (371(c) date), entitled Methods And Devices For Anchoring A Gastroenterologic Sleeve, which claims priority to International Patent Application No. PCT/US2009/032737, filed Jan. 30, 2009, entitled Methods And Devices For Anchoring A Gastroenterologic which claims benefit of and priority to U.S. Provisional Application Ser. No. 61/025,500 filed Feb. 1, 2008 entitled Methods And Devices For Anchoring A Gastroenterologic Sleeve, all of which are hereby incorporated herein by reference in their entireties.
- The present invention relates generally to improved methods and devices for anchoring a gastroenterologic sleeve within the stomach without reliance on sutures, staples, or other mechanisms that puncture the stomach wall. In addition to leaving the stomach walls free of punctures, the anchoring system of the present invention prevents movement of the sleeve in both directions, thereby preventing the sleeve from being passed through the digestive system but also from refluxing up the esophagus.
- According to the Center for Disease Control (CDC), sixty six percent of American are overweight, and thirty two percent are obese, presenting an overwhelming health problem. From an economic standpoint, it is estimated that more than 100 billion dollars are spent on obesity and treating its major co-morbidities. This figure does not include psychological and social costs. Many health care experts consider obesity the largest health problem facing westernized societies and considered obesity an epidemic. From a medical standpoint, obesity is the primary risk factor for type 2 diabetes and obstructive sleep apnea. It increases the chances for heart disease, pulmonary disease, infertility, osteoarthritis, cholecystitis and several major cancers, including breast and colon cancers. Despite these alarming facts, treatment options for obesity remain limited.
- Treatment options include dietary modification, very low-calorie liquid diets, pharmaceutical agents, counseling, exercise programs and surgery. Diet and exercise plans often fail because most individuals do not have the discipline to adhere to such plans. When diet and exercise fail, many try dietary supplements and drugs or other ingestible preparations promoted as being capable of suppressing appetite or inducing satiety. In general, these techniques for treating compulsive overeating/obesity have tended to produce only a temporary effect. The individual usually becomes discouraged and/or depressed after the initial rate of weight loss plateaus and further weight loss becomes harder to achieve. The individual then typically reverts to the previous behavior of compulsive overeating.
- Surgical procedures that restrict the size of the stomach and/or bypass parts of the intestine are the only remedies that provide lasting weight loss for the majority of morbidly obese individuals. Surgical procedures for morbid obesity are becoming more common based on long-term successful weight loss result.
- Bariatric surgery is a treatment for morbid obesity that involves alteration of a patient's digestive tract to encourage weight loss and to help maintain normal weight. Known bariatric surgery procedures include jejuno-ileal bypass, jejuno-colic shunt, biliopancreatic diversion, gastric bypass, Roux-en-Y gastric bypass, gastroplasty, gastric banding, vertical banded gastroplasty, and silastic ring gastroplasty. A more complete history of bariatric surgery can be found on the website of the American Society for Bariatric Surgery at http://www.asbs.org, the contents of which are incorporated by reference herein in their entirety.
- Most of the surgeries which create malabsorption, such as the by-pass operations, although effective in weight reduction, involve permanent modification of the GI tract and have a risk of short and long term complication and even death. By implanting a gastroenterologic sleeve, which is essentially a prosthetic liner for the stomach and/or duodenum, malabsorption can be induced without permanently modifying the GI tract. The sleeve simply provides a physical barrier between the food eaten and the absorptive stomach and duodenic walls.
- Unfortunately, present gastroenterologic sleeve designs require fastening the sleeve to the tissue of the stomach or duodenum. Typically, this is accomplished through sutures, staples, or the like. Because the interior lining of the GI tract is incredibly slippery, it is very difficult to mechanically fasten anything to them. Additionally, anytime the walls of the GI tract are punctured, there is a risk of infection and other complications.
- The methods and devices of the present invention are directed to methods and devices for implanting a gastroenterologic sleeve into the stomach and/or duodenum without using puncturing fasteners such as staples or sutures.
- In one embodiment, a plurality of pessary rings is incorporated into a sleeve such that the rings expand until they contact the stomach walls. This embodiment takes advantage of the fact that the inlet and outlet of the stomach are much smaller than the interior of the stomach. Hence, once the rings have expanded, they are too large to migrate out of the stomach.
- Another embodiment involves the use of a loose, yet expandable matrix implanted in the stomach. The matrix allows interaction between the stomach and food yet provides an anchor to which a sleeve lining the duodenum is attached. Hence, the matrix eliminates the possibility of the sleeve migrating through the intestinal tract.
- Another embodiment employs two pessary rings and a band or other constrictor, such as a lap band. The pessary rings are installed inside the esophageal-stomach junction and have an inherent expansive force. A lap band is placed around the outside of the stomach, between the pessary rings, and has a squeezing force. Hence, the pessary rings and the lap band interact to lock each other in place. A sheath, tube or sleeve is attached to the pessary rings and extends into the stomach to cause food to bypass some or all of the stomach. The sheath may also extend into the duodenum such that a portion of the small intestine is also bypassed.
-
FIG. 1 is an elevation of an embodiment of the present invention installed within a stomach; -
FIG. 2 is an elevation of an embodiment of the present invention installed within a stomach; -
FIG. 3 is an elevation of an embodiment of the present invention installed within a stomach; -
FIG. 4 is an elevation of an embodiment of the present invention installed within a stomach; and -
FIG. 5 is a perspective view of a delivery device that may be used to delivery the devices of the present invention. - Referring now to the figures and first to
FIG. 1 there is shown an embodiment of the present invention that includes adevice 10 for creating a malabsorption condition in the stomach and/or duodenum. Thedevice 10 generally includes an absorption-limiting or preventing sheath ortube 20 that is attached at aproximal end 22 to ananchoring device 40. - The
anchoring device 40 includes a plurality ofrings 42, such as pessary rings for example, connected together by thin connectors 44. Therings 42 are resilient and collapsible such that they may be compressed into elongate members for introduction into the stomach via the esophagus with a catheter or endoscope. Upon release from the delivery device, therings 42 expand and orient themselves in a spaced-apart fashion. The rings are sized and arranged according to the shape of the stomach and it is envisioned that each device will be sized proportionately to the size of the patient, if necessary. - The connectors 44 are thin, thread-like connectors that prevent the
rings 42 from twisting. The connectors 44 also function to combine therings 42 into a single anchor and further create large gaps through which food may contact the stomach walls for digestion. In the event that it is desired to prevent the food from contacting the stomach walls, the thin connectors 44 may be replaced by a sleeve-like material. It is further envisioned that a combination of thin connectors 44 and connectors made of sleeve-like material may be used to control the area of the stomach that participates in the digestive process. It is further contemplated that the thin connectors 44 may be replaced by a semi-permeable sleeve material that allows some of the food to come into contact with stomach acid for digestion. -
FIG. 2 shows another embodiment of adevice 50 of the present invention. Thedevice 50 also includes an absorption-limiting or preventing sheath ortube 20 that is attached at aproximal end 22 to an anchoring device 60. The anchoring device 60 is constructed of a loose,expandable matrix 62. Thematrix 62 is constructed such that some or all of the food entering the stomach is permitted to interact with the stomach in the digestive process. The matrix may be constructed of a self-expanding material such as Nitinol, or any suitable, digestive-resistant material. The anchoring device 60 is sized to substantially fill the stomach cavity when expanded and also to conform to the shape of the stomach, thereby providing a stable anchor for thetube 20. -
FIG. 3 shows an embodiment of adevice 70 that includes sheath 80 connected to ananchoring device 90. The sheath 80 is sized and constructed to prevent food from contacting the upper stomach, thereby limiting digestion. At its upper end, the sheath 80 is connected to theanchoring device 90, which includes components that are internal and external to the gastroesophageal junction. - The interior components of the
anchoring device 90 include two pessary rings 92, each connected to the sheath 80. The pessary rings 92 are self-expanding and, when in place, place a mild pressure on the inside of the esophagus. - The exterior components of the
anchoring device 90 include alap band 94 and aninflation device 96. Thelap band 94 is fastened around the outside of the gastroesophageal junction between the locations of the pessary rings 92. The anchoringdevice 90 also includes apump 98, such as a hand pump, connected to thelap band 94 via atube 100. Once thelap band 94 is fastened around the outside of the gastroesophageal junction between the locations of the pessary rings 92, thelap band 94 is inflated with an acceptable fluid, such that the lap band places an inward pressure on the gastroesophageal junction between the external pressure points of the pessary rings 92. In this way, thelap band 94 and the pessary rings 92 cooperate to prevent movement of theanchoring device 90. It is further contemplated that thelap band 94 can be controlled using thepump 98 to control the amount and rate that food can enter the stomach, as well as preventing gastroesophageal reflux disease (GERD). -
FIG. 4 depicts another embodiment of thedevice 70 in which asheath 110 is attached to theanchoring device 90 is longer and extends well into the duodenum. This embodiment provides a solution for completely bypassing the stomach and some or all of the duodenum. However, it is envisioned that thesheath 110 could be constructed, partly or entirely, of a semi-permeable material that allows some gastric interaction between the food and the digestive system. Doing so may prevent some of the undesirable effects of malabsorption, such as the various forms of malabsorption syndrome. - The devices of
FIGS. 1 and 2 may be implanted completely endoscopically, without the use of a general anesthesia.FIG. 5 shows one example of adelivery device 120 for use in implantingdevices delivery device 120 includes aendoscopic catheter 130 surrounded by asheath catheter 150. Aspace 152 exists between theendoscopic catheter 130 and thesheath catheter 150 that is sized to allow thedevice - The
endoscopic catheter 130 includes a pullingwire 132 with anattachment mechanism 134 at a distal end thereof. Theendoscopic catheter 130 also includes anendoscope 136 and a steering device (not shown). Preferably, a portion of theendoscopic catheter 130, such as the pullingwire 132, is radiopaque. Alternatively, radiopaque bands may be incorporated into the distal end of thedelivery device 120. - In operation, a
device delivery device 120 such that theendoscopic catheter 130 passes through the interior lumen of thedevice sheath catheter 150 surrounds the exterior of thedevice device device delivery device 120. Theattachment mechanism 134 is attached to the distal end of thedevice - The
delivery device 120 is then navigated transesophageally into and through the stomach and into the duodenum to a desired depth. Thedelivery device 120 is then retracted while the pullingwire 132 is advanced through theendoscopic catheter 130 such that the distal end of the pullingwire 132 remains somewhat stationary with respect to the duodenum. Hence, as thedelivery device 120 is retracted, the pullingwire 132 pulls thedevice attachment mechanism 134. - As the
delivery device 120 is retracted, theendoscope 136 provides an interior view of thedevice device - Once the
delivery device 120 is retracted through the stomach, and theentire device attachment device 134 is released from the distal end of thedevice wire 132 is retracted into theendoscopic catheter 130. Then theentire delivery device 120 is removed from the body. - The
delivery device 120 may be similarly used to deploy thedevice 70 ofFIGS. 3 and 4 . However, laparoscopic installation of thelap band 94 is also required. - Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/698,816 US20200093585A1 (en) | 2008-02-01 | 2019-11-27 | Methods And Devices For Anchoring A Gastroenterologic Sleeve |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2550008P | 2008-02-01 | 2008-02-01 | |
PCT/US2009/032737 WO2009097582A1 (en) | 2008-02-01 | 2009-01-30 | Methods and devices for anchoring a gastroenterologic sleeve |
US86570610A | 2010-12-15 | 2010-12-15 | |
US16/698,816 US20200093585A1 (en) | 2008-02-01 | 2019-11-27 | Methods And Devices For Anchoring A Gastroenterologic Sleeve |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/865,706 Continuation US10517709B2 (en) | 2008-02-01 | 2009-01-30 | Methods and devices for anchoring a gastroenterologic sleeve |
PCT/US2009/032737 Continuation WO2009097582A1 (en) | 2008-02-01 | 2009-01-30 | Methods and devices for anchoring a gastroenterologic sleeve |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200093585A1 true US20200093585A1 (en) | 2020-03-26 |
Family
ID=40913289
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/865,706 Active 2031-04-17 US10517709B2 (en) | 2008-02-01 | 2009-01-30 | Methods and devices for anchoring a gastroenterologic sleeve |
US16/698,816 Pending US20200093585A1 (en) | 2008-02-01 | 2019-11-27 | Methods And Devices For Anchoring A Gastroenterologic Sleeve |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/865,706 Active 2031-04-17 US10517709B2 (en) | 2008-02-01 | 2009-01-30 | Methods and devices for anchoring a gastroenterologic sleeve |
Country Status (4)
Country | Link |
---|---|
US (2) | US10517709B2 (en) |
EP (1) | EP2240092A4 (en) |
AU (1) | AU2009208951A1 (en) |
WO (1) | WO2009097582A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9060844B2 (en) | 2002-11-01 | 2015-06-23 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
WO2005110280A2 (en) | 2004-05-07 | 2005-11-24 | Valentx, Inc. | Devices and methods for attaching an endolumenal gastrointestinal implant |
US20090093767A1 (en) * | 2007-10-04 | 2009-04-09 | Brian Kelleher | Devices and methods for endolumenal therapy |
EP2240092A4 (en) * | 2008-02-01 | 2015-05-06 | Medical And Surgical Review P C | Methods and devices for anchoring a gastroenterologic sleeve |
US9278019B2 (en) | 2009-04-03 | 2016-03-08 | Metamodix, Inc | Anchors and methods for intestinal bypass sleeves |
US9173760B2 (en) | 2009-04-03 | 2015-11-03 | Metamodix, Inc. | Delivery devices and methods for gastrointestinal implants |
US8211186B2 (en) | 2009-04-03 | 2012-07-03 | Metamodix, Inc. | Modular gastrointestinal prostheses |
IN2012DN00316A (en) | 2009-07-10 | 2015-05-08 | Metamodix Inc | |
US8636683B2 (en) * | 2010-01-14 | 2014-01-28 | Pavilion Medical Innovations, Llc | Systems and methods for bariatric therapy |
CN102781369B (en) * | 2010-01-14 | 2015-03-11 | 亭阁医疗创新公司 | Systems and methods for bariatric therapy |
US8956318B2 (en) | 2012-05-31 | 2015-02-17 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9681975B2 (en) | 2012-05-31 | 2017-06-20 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9451960B2 (en) | 2012-05-31 | 2016-09-27 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
WO2013185830A1 (en) * | 2012-06-14 | 2013-12-19 | Ethicon Endo-Surgery, Inc. | Devices and methods for anchoring an endoluminal sleeve in the gi tract |
US9320640B2 (en) | 2012-06-29 | 2016-04-26 | The Procter & Gamble Company | Method of attaching a withdrawal member to a pessary device |
US20140114126A1 (en) * | 2012-10-23 | 2014-04-24 | Boston Scientific Scimed, Inc. | Universal endoscope attachment system and related methods of use |
US10159699B2 (en) | 2013-01-15 | 2018-12-25 | Metamodix, Inc. | System and method for affecting intestinal microbial flora |
US9757264B2 (en) | 2013-03-13 | 2017-09-12 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
CZ308131B6 (en) * | 2013-09-16 | 2020-01-15 | Volenec RD Int., s.r.o. | Bariatric implant |
US10172735B2 (en) * | 2014-04-05 | 2019-01-08 | Rex Medical, L.P | Duodenum sleeve for treating obesity |
US9622897B1 (en) | 2016-03-03 | 2017-04-18 | Metamodix, Inc. | Pyloric anchors and methods for intestinal bypass sleeves |
WO2017201424A1 (en) | 2016-05-19 | 2017-11-23 | Metamodix, Inc. | Pyloric anchor retrieval tools and methods |
US11350958B2 (en) * | 2018-05-11 | 2022-06-07 | Boston Scientific Scimed, Inc. | Full-circumferential tissue resectioning |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030040804A1 (en) * | 2001-08-27 | 2003-02-27 | Stack Richard S. | Satiation devices and methods |
US20080234834A1 (en) * | 2003-12-09 | 2008-09-25 | Gi Dynamics, Inc. | Gastrointestinal implant with drawstring |
US10517709B2 (en) * | 2008-02-01 | 2019-12-31 | Ballast Medical Inc. | Methods and devices for anchoring a gastroenterologic sleeve |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4592339A (en) | 1985-06-12 | 1986-06-03 | Mentor Corporation | Gastric banding device |
US5074868A (en) * | 1990-08-03 | 1991-12-24 | Inamed Development Company | Reversible stoma-adjustable gastric band |
US5431640A (en) * | 1994-11-09 | 1995-07-11 | The Medical Center Of Central Georgia | Method and apparatus for duodenal intubation of a patient |
US5820584A (en) * | 1997-08-28 | 1998-10-13 | Crabb; Jerry A. | Duodenal insert and method of use |
WO2002102435A2 (en) * | 2001-06-14 | 2002-12-27 | Artes Medical Usa, Inc. | Medical injection apparatus |
US6755869B2 (en) | 2001-11-09 | 2004-06-29 | Boston Scientific Corporation | Intragastric prosthesis for the treatment of morbid obesity |
US8398669B2 (en) | 2002-04-09 | 2013-03-19 | Jae-Hwang Kim | Indwelling fecal diverting device |
US7220237B2 (en) * | 2002-10-23 | 2007-05-22 | Satiety, Inc. | Method and device for use in endoscopic organ procedures |
US7037344B2 (en) * | 2002-11-01 | 2006-05-02 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US9060844B2 (en) * | 2002-11-01 | 2015-06-23 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US7314489B2 (en) | 2003-08-20 | 2008-01-01 | Ethicon Endo-Surgery, Inc. | Method and apparatus to facilitate nutritional malabsorption |
US20050247320A1 (en) * | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
AU2005287010B2 (en) * | 2004-09-17 | 2010-04-15 | Gi Dynamics, Inc. | Gastrointestinal anchor |
AU2006227251A1 (en) | 2005-03-18 | 2006-09-28 | George Adaniya | Gastric bypass prosthesis fixation system and method for treatment of obesity |
-
2009
- 2009-01-30 EP EP09706642.7A patent/EP2240092A4/en not_active Withdrawn
- 2009-01-30 US US12/865,706 patent/US10517709B2/en active Active
- 2009-01-30 WO PCT/US2009/032737 patent/WO2009097582A1/en active Application Filing
- 2009-01-30 AU AU2009208951A patent/AU2009208951A1/en not_active Abandoned
-
2019
- 2019-11-27 US US16/698,816 patent/US20200093585A1/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030040804A1 (en) * | 2001-08-27 | 2003-02-27 | Stack Richard S. | Satiation devices and methods |
US20080234834A1 (en) * | 2003-12-09 | 2008-09-25 | Gi Dynamics, Inc. | Gastrointestinal implant with drawstring |
US10517709B2 (en) * | 2008-02-01 | 2019-12-31 | Ballast Medical Inc. | Methods and devices for anchoring a gastroenterologic sleeve |
Also Published As
Publication number | Publication date |
---|---|
EP2240092A4 (en) | 2015-05-06 |
US20110098630A1 (en) | 2011-04-28 |
EP2240092A1 (en) | 2010-10-20 |
US10517709B2 (en) | 2019-12-31 |
WO2009097582A1 (en) | 2009-08-06 |
AU2009208951A1 (en) | 2009-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200093585A1 (en) | Methods And Devices For Anchoring A Gastroenterologic Sleeve | |
US9320524B2 (en) | Methods and devices for endoscopically creating an anastomosis | |
US7794447B2 (en) | Gastrointestinal sleeve device and methods for treatment of morbid obesity | |
US7037344B2 (en) | Apparatus and methods for treatment of morbid obesity | |
US9155608B2 (en) | Devices and methods for treatment of obesity | |
EP2561839B1 (en) | Device for anchoring an endoluminal sleeve in the GI tract | |
US20180228632A1 (en) | Devices and Methods for Anchoring an Endoluminal Sleeve in the GI Tract | |
WO2004041133A1 (en) | Apparatus and methods for treatment of morbid obesity | |
AU2009208954A1 (en) | Methods and devices for performing gastroplasty | |
WO2013023675A1 (en) | Devices for anchoring an endoluminal sleeve in the gi tract | |
WO2013026473A1 (en) | Devices and methods for anchoring an endoluminal sleeve in the gi tract | |
EP3597156B1 (en) | Gastrointestinal implant and method for deploying the same | |
EP2603180B1 (en) | Adapter for stomach devices | |
US20220125434A1 (en) | Single anastomosis gastrointestinal tract bypass endoscopic systems and methods | |
US20130197562A1 (en) | Gastric Stretch Devices, and Methods for Treatment of Obesity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GT METABOLIC SOLUTIONS, INC., DELAWARE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BALLAST MEDICAL, INC.;REEL/FRAME:056048/0357 Effective date: 20210413 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |